- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 24.96M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $299.8M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $289.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.26B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.21B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $357.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $371.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $508.9M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $518.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $977.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $956.6M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.77B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.73B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 25.07M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $400K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $80.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.65 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.66 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $90.5M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $14M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $50.5M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $155.7M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $344.5M |
| Revenue | Q1 2025 · Mar 31, 2024 | $500.2M |